These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Monitoring the safety of COVID-19 vaccines in pregnancy in the US. Moro PL; Panagiotakopoulos L; Oduyebo T; Olson CK; Myers T Hum Vaccin Immunother; 2021 Dec; 17(12):4705-4713. PubMed ID: 34756131 [TBL] [Abstract][Full Text] [Related]
8. Vaccine safety in Australia during the COVID-19 pandemic: Lessons learned on the frontline. Laemmle-Ruff I; Lewis G; Clothier HJ; Dimaguila GL; Wolthuizen M; Buttery J; Crawford NW Front Public Health; 2022; 10():1053637. PubMed ID: 36408022 [TBL] [Abstract][Full Text] [Related]
9. COVID-19 vaccine safety inquiries to the centers for disease control and prevention immunization safety office. Miller ER; Moro PL; Shimabukuro TT; Carlock G; Davis SN; Freeborn EM; Roberts AL; Gee J; Taylor AW; Gallego R; Suragh T; Su JR Vaccine; 2023 Jun; 41(27):3960-3963. PubMed ID: 37248099 [TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial. Akova M; Unal S Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629 [TBL] [Abstract][Full Text] [Related]
12. Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5-11 Years - United States, October 12-January 1, 2023. Hause AM; Marquez P; Zhang B; Su JR; Myers TR; Gee J; Panchanathan SS; Thompson D; Shimabukuro TT; Shay DK MMWR Morb Mortal Wkly Rep; 2023 Jan; 72(2):39-43. PubMed ID: 36634021 [TBL] [Abstract][Full Text] [Related]
13. Safety monitoring of bivalent mRNA COVID-19 vaccine among pregnant persons in the vaccine adverse event reporting System - United States, September 1, 2022 - March 31, 2023. Moro PL; Carlock G; Fifadara N; Habenicht T; Zhang B; Strid P; Marquez P Vaccine; 2024 Apr; 42(9):2380-2384. PubMed ID: 38462432 [TBL] [Abstract][Full Text] [Related]
14. Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices - United States, December 2021. Oliver SE; Wallace M; See I; Mbaeyi S; Godfrey M; Hadler SC; Jatlaoui TC; Twentyman E; Hughes MM; Rao AK; Fiore A; Su JR; Broder KR; Shimabukuro T; Lale A; Shay DK; Markowitz LE; Wharton M; Bell BP; Brooks O; McNally V; Lee GM; Talbot HK; Daley MF MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(3):90-95. PubMed ID: 35051137 [TBL] [Abstract][Full Text] [Related]
15. Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS). Shimabukuro TT; Nguyen M; Martin D; DeStefano F Vaccine; 2015 Aug; 33(36):4398-405. PubMed ID: 26209838 [TBL] [Abstract][Full Text] [Related]
16. Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12-17 Years - United States, December 9, 2021-February 20, 2022. Hause AM; Baggs J; Marquez P; Abara WE; Olubajo B; Myers TR; Su JR; Thompson D; Gee J; Shimabukuro TT; Shay DK MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(9):347-351. PubMed ID: 35239637 [TBL] [Abstract][Full Text] [Related]
17. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021. Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735 [TBL] [Abstract][Full Text] [Related]
18. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021. Gargano JW; Wallace M; Hadler SC; Langley G; Su JR; Oster ME; Broder KR; Gee J; Weintraub E; Shimabukuro T; Scobie HM; Moulia D; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Oliver SE MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(27):977-982. PubMed ID: 34237049 [TBL] [Abstract][Full Text] [Related]
19. Safety Monitoring of Pfizer-BioNTech COVID-19 Vaccine Booster Doses Among Children Aged 5-11 Years - United States, May 17-July 31, 2022. Hause AM; Baggs J; Marquez P; Myers TR; Su JR; Hugueley B; Thompson D; Gee J; Shimabukuro TT; Shay DK MMWR Morb Mortal Wkly Rep; 2022 Aug; 71(33):1047-1051. PubMed ID: 35980875 [TBL] [Abstract][Full Text] [Related]
20. Anxiety-Related Adverse Event Clusters After Janssen COVID-19 Vaccination - Five U.S. Mass Vaccination Sites, April 2021. Hause AM; Gee J; Johnson T; Jazwa A; Marquez P; Miller E; Su J; Shimabukuro TT; Shay DK MMWR Morb Mortal Wkly Rep; 2021 May; 70(18):685-688. PubMed ID: 33956781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]